HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Cediranib for alveolar soft part sarcoma: a randomised study in relation to clinical practice.

AuthorsSandro Pasquali, Silvia Stacchiotti
JournalThe Lancet. Oncology (Lancet Oncol) Vol. 20 Issue 7 Pg. 901-903 (07 2019) ISSN: 1474-5488 [Electronic] England
PMID31160250 (Publication Type: Journal Article, Comment)
Chemical References
  • Quinazolines
  • cediranib
Topics
  • Double-Blind Method
  • Humans
  • Quinazolines
  • Sarcoma, Alveolar Soft Part

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: